BIOCRYST PHARMACEUTICALS, INC. (BCRX) Net income 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$263.9MFY2025 · since FY2016: -$55.1M → $263.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $263.9M | +396.9% |
| FY2024 | -$88.9M | +60.8% |
| FY2023 | -$226.5M | +8.3% |
| FY2022 | -$247.1M | -34.3% |
| FY2021 | -$184.1M | -0.7% |
| FY2020 | -$182.8M | -67.9% |
| FY2019 | -$108.9M | -7.6% |
| FY2018 | -$101.3M | -53.9% |
| FY2017 | -$65.8M | -19.3% |
| FY2016 | -$55.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice